Sorg Elaine K.
Insider CIK 1832571 · ABBV SVP, US Commercial Operations · ARTV Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2026-09-10 | 2026-09-14 | 16,250 | — | $0 | 16,250 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2026-09-10 | 2026-09-14 | 16,250 | — | $0 | 16,250 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2026-09-08 | 2026-09-08 | 13,750 | — | $0 | 13,750 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2026-09-08 | 2026-09-08 | 13,750 | — | $0 | 13,750 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2026-02-18 | 2026-02-19 | 27,500 | — | $0 | 27,500 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2023-04-25 | 2023-04-27 | 6,130 | $144.54 | $886.0K | 12,258 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2023-04-25 | 2023-04-27 | 6,130 | $144.54 | $886.0K | 41,460 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2023-04-25 | 2023-04-27 | 6,130 | $165.00 | $1.01M | 35,330 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2023-04-17 | 2023-04-19 | 6,999 | $161.64 | $1.13M | 35,830 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2023-04-17 | 2023-04-19 | 500 | $162.04 | $81.0K | 35,330 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2023-04-03 | 2023-04-05 | 15,002 | $93.50 | $1.40M | 0 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2023-04-03 | 2023-04-05 | 15,002 | $160.03 | $2.40M | 42,829 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2023-04-03 | 2023-04-05 | 15,002 | $93.50 | $1.40M | 57,831 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2023-03-01 | 2023-03-02 | 15,003 | $93.50 | $1.40M | 0 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2023-03-01 | 2023-03-02 | 15,003 | $155.00 | $2.33M | 42,829 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2023-03-01 | 2023-03-02 | 15,003 | $93.50 | $1.40M | 57,832 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2023-02-28 | 2023-03-02 | 19,850 | $154.28 | $3.06M | 42,829 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2023-02-21 | 2023-02-21 | 15,321 | $105.92 | $1.62M | 7,660 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2023-02-21 | 2023-02-21 | 6,901 | $150.74 | $1.04M | 71,099 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2023-02-21 | 2023-02-21 | 15,321 | $105.92 | $1.62M | 78,000 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2023-02-21 | 2023-02-21 | 8,420 | $151.29 | $1.27M | 62,679 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2023-02-16 | 2023-02-21 | 13,166 | — | $0 | 13,166 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2023-02-16 | 2023-02-21 | 3,874 | — | $0 | 62,679 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2023-02-16 | 2023-02-21 | 6,861 | — | $0 | 54,147 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2023-02-16 | 2023-02-21 | 29,410 | — | $0 | 47,286 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2023-02-16 | 2023-02-21 | 4,658 | — | $0 | 58,805 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2022-03-01 | 2022-03-01 | 2,333 | $147.59 | $344.3K | 22,027 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2022-03-01 | 2022-03-01 | 3,451 | $148.59 | $512.8K | 18,576 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2022-03-01 | 2022-03-01 | 700 | $149.07 | $104.3K | 17,876 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2022-02-25 | 2022-03-01 | 11,125 | $149.54 | $1.66M | 24,360 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2022-02-17 | 2022-02-22 | 18,388 | — | $0 | 18,388 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2022-02-17 | 2022-02-22 | 4,075 | — | $0 | 25,108 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2022-02-17 | 2022-02-22 | 11,642 | — | $0 | 11,642 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2022-02-17 | 2022-02-22 | 2,530 | — | $0 | 14,172 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2022-02-17 | 2022-02-22 | 10,377 | — | $0 | 35,485 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2022-02-17 | 2022-02-22 | 6,861 | — | $0 | 21,033 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2021-12-13 | 2021-12-14 | 3,229 | $125.85 | $406.4K | 0 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2021-12-13 | 2021-12-14 | 3,229 | $125.85 | $406.4K | 3,229 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2021-12-10 | 2021-12-14 | 5,137 | $124.15 | $637.8K | 6,458 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2021-08-23 | 2021-08-25 | 7,080 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2021-08-23 | 2021-08-25 | 6,000 | $120.00 | $720.0K | 11,595 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2021-08-23 | 2021-08-25 | 7,080 | $114.36 | $809.7K | 18,675 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2021-08-23 | 2021-08-25 | 7,080 | $120.00 | $849.6K | 11,595 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2021-03-01 | 2021-03-02 | 4,219 | $108.61 | $458.2K | 21,816 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2021-03-01 | 2021-03-02 | 4,221 | $108.61 | $458.4K | 17,595 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2021-02-28 | 2021-03-02 | 6,716 | $107.74 | $723.6K | 26,035 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2021-02-22 | 2021-02-24 | 15,003 | — | $0 | 30,005 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2021-02-22 | 2021-02-24 | 5,192 | — | $0 | 5,192 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2021-02-22 | 2021-02-24 | 200 | $105.28 | $21.1K | 32,751 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2021-02-22 | 2021-02-24 | 15,003 | $93.50 | $1.40M | 47,754 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2021-02-22 | 2021-02-24 | 5,192 | $79.02 | $410.3K | 52,946 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2021-02-22 | 2021-02-24 | 19,995 | $104.71 | $2.09M | 32,951 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2021-02-18 | 2021-02-22 | 22,981 | — | $0 | 22,981 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2021-02-18 | 2021-02-22 | 6,863 | — | $0 | 32,751 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2021-02-18 | 2021-02-22 | 4,454 | — | $0 | 22,049 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2021-02-18 | 2021-02-22 | 1,309 | — | $0 | 23,358 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2021-02-18 | 2021-02-22 | 2,530 | — | $0 | 25,888 | SEC↗ |